Strategic Collaboration Terumo BCT is actively pursuing collaboration with biopharma and cell therapy developers (e.g., TrAMPoline Pharma, Steminent Biotherapeutics, Taiwan Bio, Precision Bio) to automate manufacturing and streamline workflows, presenting opportunities to offer integrated automation, workflow optimization, and scalable manufacturing solutions.

Automation Focus Recent news highlights automated manufacturing for TIL therapies and MES/MSC expansion workflows, indicating strong demand for automated, scalable cell therapy production—ideal for selling automation platforms, process control software, and consulting services.

Clinical to Commercial Partnerships aimed at supporting clinical-scale production with future scale-up signals a path to accompany customers from clinical development through to commercial manufacturing, suggesting opportunities in transition services, validation packages, and compliance support.

Global Reach With presence in over 160 countries and a diversified portfolio spanning apheresis, whole blood processing, and pathogen reduction, there is potential to cross-sell across product lines to large hospital systems, blood centers, and research institutions worldwide.

Thought Leadership Leadership recognition and active community involvement, alongside strategic R&D and education grants, create openings for joint educational programs, funded research collaborations, and customer education services that align with sales of equipment, service contracts, and training.